Benzinga | Oct 8, 2020 05:39AM EDT

Curevac CTO Fotin-mleczek Says Hope to Have Trial Data on Immune Response to Covid-19 Vaccine Candidate by End of Month; Start Phase 2/3 Trial by the End of Year

-Reuters